ARTICLE | Product Development
Two-pronged attack
February 29, 2016 8:00 AM UTC
Oncolytic viruses can stimulate both direct and indirect killing of cancer cells, as illustrated by Imlygic talimogene laherparepvec (T-Vec) from Amgen Inc. (NASDAQ:AMGN). Imlygic is a modified herpes...